Friday, 12 June 2009

Low Dose Naltrexone : The Next Miracle Drug?

by Michael D. Shaw, Exec VP, Interscan Corporation

"LDN is inexpensive with virtually no harmful side effects. However, since it is no longer a proprietary drug, the pace of rolling out clinical trials for the off-label effects described in this article will probably be slow, as will its acceptance by mainstream medicine. Still, there is nothing to prevent a patient from taking an FDA approved drug for an off-label indication, and this practice goes on all the time.

Certainly, there is much appeal in a naturally-acting immune modulator that is cheap and effective. We await the publication of further results."

No comments:

Post a Comment